{"DataElement":{"publicId":"8026535","version":"1","preferredName":"Biospecimen Assay Technology Type","preferredDefinition":"The type of assay method or technology utilized to visualize a cell or tissue specimen.","longName":"8026534v1.0:7789187v1.0","context":"HTAN","contextVersion":"1","DataElementConcept":{"publicId":"8026534","version":"1","preferredName":"Biospecimen Assay Technology Type","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The type of a technology on which an assay is based.","longName":"2859635v1.0:7789183v1.0","context":"HTAN","contextVersion":"1","ObjectClass":{"publicId":"2859635","version":"1","preferredName":"Biospecimen","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66832E51-39F3-1736-E040-BB89AD4349FB","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"UMLLOADER_TAVERNA","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7789183","version":"1","preferredName":"Assay Technology Type","preferredDefinition":"The type of a technology on which an assay is based.","longName":"C178865","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assay Technology Type","conceptCode":"C178865","definition":"The type of a technology on which an assay is based.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0DCB6B-40F6-54BD-E053-4EBD850AD77D","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HTAN:Human Tumor Atlas Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D71E0570-73FA-67F2-E053-4EBD850AD165","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-02-03","modifiedBy":"KNABLEJ","dateModified":"2022-03-31","changeDescription":"3/31/22 jk released for HTAN use.  2/3/22 jk created for SRRS Biospecimen upload data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7789187","version":"1","preferredName":"Assay Technology Type","preferredDefinition":"The type of a technology on which an assay is based._Something distinguishable as an identifiable class based on common qualities.","longName":"7789187v1.0","context":"HTAN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"H&E","valueDescription":"Hematoxylin and Eosin Staining Method","ValueMeaning":{"publicId":"4588572","version":"1","preferredName":"Hematoxylin and Eosin Staining Method","longName":"4588572","preferredDefinition":"Hematoxylin-and-eosin, or H&E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematoxylin and Eosin Staining Method","conceptCode":"C23011","definition":"Hematoxylin-and-eosin, or H&E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07B015A7-389E-0E2A-E050-BB89AD433990","latestVersionIndicator":"Yes","beginDate":"2014-11-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-11-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-D9F0-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"SABER","valueDescription":"Stereotactic Ablative Radiotherapy","ValueMeaning":{"publicId":"7789189","version":"1","preferredName":"Stereotactic Ablative Radiotherapy","longName":"7789189","preferredDefinition":"A highly focused radiation therapy which delivers an intense dose of radiation to a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stereotactic Ablative Radiotherapy","conceptCode":"C157991","definition":"A highly focused radiation therapy which delivers an intense dose of radiation to a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-D9FE-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-DA17-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"MxIF","valueDescription":"Multiplexed Immunofluorescence","ValueMeaning":{"publicId":"7789190","version":"1","preferredName":"Multiplexed Immunofluorescence","longName":"7789190","preferredDefinition":"A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiplexed Immunofluorescence","conceptCode":"C181928","definition":"A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunofluorescence techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-DA23-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-DA3C-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"mIHC","valueDescription":"Multiplexed Immunohistochemistry","ValueMeaning":{"publicId":"7789191","version":"1","preferredName":"Multiplexed Immunohistochemistry","longName":"7789191","preferredDefinition":"A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunohistochemistry techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiplexed Immunohistochemistry","conceptCode":"C181927","definition":"A method that enables simultaneous detection of multiple biomarkers on a single tissue section using immunohistochemistry techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-DA48-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-DA61-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"IHC","valueDescription":"Immunohistochemistry Staining Method","ValueMeaning":{"publicId":"3031358","version":"1","preferredName":"Immunohistochemistry Staining Method","longName":"3031358","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F6B5AD-3994-79F8-E040-BB89AD430E7D","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-29","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-DA6B-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"t-CyCIF","valueDescription":"Tissue-Based Cyclic Immunofluorescence","ValueMeaning":{"publicId":"7789192","version":"1","preferredName":"Tissue-Based Cyclic Immunofluorescence","longName":"7789192","preferredDefinition":"A method for immunofluorescence imaging of formalin-fixed, paraffin-embedded (FFPE) specimens mounted on glass slides that generates images using an iterative, cycling process in which conventional fluorescence images capturing up to 60 targets are repeatedly collected from the same sample and then assembled into a high-dimensional representation of the spacial relationships between the multiplex targets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue-Based Cyclic Immunofluorescence","conceptCode":"C181929","definition":"A method for immunofluorescence imaging of formalin-fixed, paraffin-embedded (FFPE) specimens mounted on glass slides that generates images using an iterative, cycling process in which conventional fluorescence images capturing up to 60 targets are repeatedly collected from the same sample and then assembled into a high-dimensional representation of the spacial relationships between the multiplex targets.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-DA78-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0F6B3A-DA91-7612-E053-4EBD850AB30E","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"IMC","valueDescription":"Imaging Mass Cytometry","ValueMeaning":{"publicId":"7789409","version":"1","preferredName":"Imaging Mass Cytometry","longName":"7789409","preferredDefinition":"A proprietary method that combines laser ablation of tissue specimens with secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. This technique allows for in situ characterization of the specimen while preserving its tissue architecture and cellular morphology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Imaging Mass Cytometry","conceptCode":"C182027","definition":"A proprietary method that combines laser ablation of tissue specimens with secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. This technique allows for in situ characterization of the specimen while preserving its tissue architecture and cellular morphology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD13C642-2235-2742-E053-4EBD850A7903","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD13C642-224E-2742-E053-4EBD850A7903","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"GeoMX-DSP","valueDescription":"GeoMx Digital Spatial Profiler","ValueMeaning":{"publicId":"7789193","version":"1","preferredName":"GeoMx Digital Spatial Profiler","longName":"7789193","preferredDefinition":"A method to stain for RNA or protein from tissue sections that combines spatial and molecular profiling technologies by generating a whole tissue image at single cell resolution along with digital profiling data. A tissue section is reacted with up to 4 fluorescent morphology markers and tens to thousands of RNA or protein detection reagents barcoded with unique photocleavable oligonucleotides. The oligonucleotide markers are then imaged from regions of interest to be identified and quantitated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GeoMx Digital Spatial Profiler","conceptCode":"C181933","definition":"A method to stain for RNA or protein from tissue sections that combines spatial and molecular profiling technologies by generating a whole tissue image at single cell resolution along with digital profiling data. A tissue section is reacted with up to 4 fluorescent morphology markers and tens to thousands of RNA or protein detection reagents barcoded with unique photocleavable oligonucleotides. The oligonucleotide markers are then imaged from regions of interest to be identified and quantitated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0FFA4E-70D2-1D16-E053-4EBD850A3DC8","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0FFA4E-70EB-1D16-E053-4EBD850A3DC8","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"CODEX","valueDescription":"CO-Detection by indEXing","ValueMeaning":{"publicId":"7789194","version":"1","preferredName":"CO-Detection by indEXing","longName":"7789194","preferredDefinition":"A highly multiplexed cytometric imaging approach used to create multiplexed datasets for a single tissue staining reaction. CODEX iteratively visualizes antibody binding events using DNA barcodes, fluorescent dNTP analogs, and an in situ polymerization-based indexing procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CO-Detection by indEXing","conceptCode":"C181931","definition":"A highly multiplexed cytometric imaging approach used to create multiplexed datasets for a single tissue staining reaction. CODEX iteratively visualizes antibody binding events using DNA barcodes, fluorescent dNTP analogs, and an in situ polymerization-based indexing procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0FFA4E-70F7-1D16-E053-4EBD850A3DC8","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0FFA4E-7110-1D16-E053-4EBD850A3DC8","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"MIBI","valueDescription":"Multiplexed Ion Beam Imaging","ValueMeaning":{"publicId":"7789195","version":"1","preferredName":"Multiplexed Ion Beam Imaging","longName":"7789195","preferredDefinition":"A method for multiplexed immunohistochemistry that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. This technique enables comprehensive phenotypic profiling and spatial analysis of the tissue microenvironment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiplexed Ion Beam Imaging","conceptCode":"C181930","definition":"A method for multiplexed immunohistochemistry that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. This technique enables comprehensive phenotypic profiling and spatial analysis of the tissue microenvironment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0FFEEB-509A-08D1-E053-4EBD850A193A","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD0FFEEB-50B3-08D1-E053-4EBD850A193A","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7789186","version":"1","preferredName":"Assay Technology Type Type","preferredDefinition":"The type of a technology on which an assay is based.:Something distinguishable as an identifiable class based on common qualities.","longName":"C178865:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assay Technology Type","conceptCode":"C178865","definition":"The type of a technology on which an assay is based.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-D9C7-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HTAN:Human Tumor Atlas Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD0F6B3A-D9D8-7612-E053-4EBD850AB30E","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"KNABLEJ","dateModified":"2022-02-25","changeDescription":"2/25/22 jk apprvd by SME, released for SRRS imaging data set.  9/28/21 jk HTAN Level 2 imaging data element, created for SRRS imaging data set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7576399","version":"1","longName":"HTAN Biospecimen CDEs","context":"HTAN","ClassificationSchemeItems":[{"publicId":"7577840","version":"1","longName":"Tier 2 Assay-specific","context":"HTAN"}]},{"publicId":"7639423","version":"1","longName":"SRRS-Standardized Repository of Reference Specimens","context":"HTAN","ClassificationSchemeItems":[{"publicId":"7639046","version":"1","longName":"SRRS Biospecimen","context":"HTAN"}]}],"AlternateNames":[{"name":"ASSAY_TYPE","type":"HTAN Alt Name","context":"HTAN"}],"ReferenceDocuments":[{"name":"Assay Type","type":"Preferred Question Text","description":"Assay Type","url":null,"context":"HTAN"},{"name":"HTAN Term","type":"Alternate Question Text","description":"Assay Type","url":null,"context":"HTAN"}],"origin":"HTAN:Human Tumor Atlas Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D71E3D21-98FB-64C1-E053-4EBD850AEC06","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2022-02-03","modifiedBy":"KNABLEJ","dateModified":"2022-03-31","changeDescription":"3/31/22 jk released for HTAN use.  2/3/22 jk created for SRRS Biospecimen upload data set; shared VD with imaging assay type (7789187).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}